Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,709 JPY | 0.00% | +10.30% | 0.00% |
05:24pm | Sight Sciences Says it Obtained $34 Million Patent Infringement Verdict Against Alcon -- Shares Jump | MT |
05:23pm | X4 Pharmaceuticals' Xolremdi Approved by FDA For WHIM Syndrome | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 2.04B | |
+9.33% | 323B | |
+14.79% | 76.06B | |
-7.14% | 67.53B | |
+3.41% | 31.21B | |
+21.34% | 23.54B | |
+10.91% | 14.15B | |
+14.03% | 10.19B | |
+17.59% | 9.07B | |
-7.14% | 6.59B |
- Stock Market
- Equities
- 141A Stock
- News Trial Holdings Inc.
- NervGen Pharma Closes C$23 Million Bought Deal Financing